Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
11
×
fda
11
×
life sciences
national blog main
clinical trials
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
biotech
san francisco blog main
san francisco top stories
indiana blog main
indiana top stories
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
cancer
eli lilly
patisiran
teva pharmaceutical
akcea therapeutics
amgen
calcitonin gene-related peptide
deals
What
fda
11
×
drug
medicine
approved
new
ago
alnylam
approval
rna
bio
cells
class
companies
decades
decision
drugs
interference
make
migraine
oks
pharmaceuticals
rnai
roundup
second
time
treatment
uses
weeks
won
ahead
announced
approve
approves
arguments
asco
awaits
battle
big
biological
branded
Language
Current search:
fda
×
drugs
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@xconomy.com
5 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing